A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.

A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial. J Thorac Oncol. 2012 Mar; 7(3):574-8.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Bridged-Ring Compounds
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Ethers, Cyclic
Female
Follow-Up Studies
Furans
Humans
Ketones
Lung Neoplasms
Macrolides
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Platinum
Salvage Therapy
Survival Rate
Taxoids
Treatment Outcome

authors with profiles

Philip Charles Hoffman
Everett E. Vokes